HEALTH● LOWJul 31 · Jul 31, 2026, 5:09 PM
Pfizer Drug Restores Pigment in Late-Stage Vitiligo Trials
Human Progress
“Pfizer said on Thursday its oral drug helped restore skin color in patients with a common form of vitiligo in two late-stage trials… The U.S. drugmaker was testing Litfulo in patients with nonsegmental vitiligo, the most common type of the disease, which causes patches of skin to lose pigment. Pfizer said both studies showed significantly […] The post Pfizer Drug Restores Pigment in Late-Stage Vitiligo Trials appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH14m agoHyderabad’s Osmania General Hospital strengthens gender-affirming surgical care for transgender peopleThe HinduHEALTHBREAKING36m agoJUST IN: Ebola: Nigeria identifies 53 contacts linked to confirmed casePremium TimesHEALTH42m agoEbola: Uganda Announces 21-Day Quarantine For Returnees From DR CongoChannels TVHEALTH1h agoLluís Benítez, veterinary oncologist: “It is known, statistically, that cancer is the cause of death for half of dogs over 10 years old”Clarín